Found 3 hits for monomerid = 50390077 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Sodium channel protein type 9 subunit alpha
(Homo sapiens (Human)) | BDBM50390077
(CHEMBL2069404)Show SMILES CN1CCN(CC1)c1cccc2OC[C@H](Cc12)NC(=O)c1nn(nc1C)-c1ccc(C)cc1C |r| Show InChI InChI=1S/C26H32N6O2/c1-17-8-9-22(18(2)14-17)32-28-19(3)25(29-32)26(33)27-20-15-21-23(6-5-7-24(21)34-16-20)31-12-10-30(4)11-13-31/h5-9,14,20H,10-13,15-16H2,1-4H3,(H,27,33)/t20-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 158 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description Inhibition of human NaV1.7 expressed in HEK293 cells by whole-cell voltage clamp assay |
Bioorg Med Chem Lett 22: 5618-24 (2012)
Article DOI: 10.1016/j.bmcl.2012.06.105 BindingDB Entry DOI: 10.7270/Q2ZC83ZX |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50390077
(CHEMBL2069404)Show SMILES CN1CCN(CC1)c1cccc2OC[C@H](Cc12)NC(=O)c1nn(nc1C)-c1ccc(C)cc1C |r| Show InChI InChI=1S/C26H32N6O2/c1-17-8-9-22(18(2)14-17)32-28-19(3)25(29-32)26(33)27-20-15-21-23(6-5-7-24(21)34-16-20)31-12-10-30(4)11-13-31/h5-9,14,20H,10-13,15-16H2,1-4H3,(H,27,33)/t20-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by IonWorks HT assay |
Bioorg Med Chem Lett 22: 5618-24 (2012)
Article DOI: 10.1016/j.bmcl.2012.06.105 BindingDB Entry DOI: 10.7270/Q2ZC83ZX |
More data for this Ligand-Target Pair | |
Sodium channel protein type 5 subunit alpha
(Homo sapiens (Human)) | BDBM50390077
(CHEMBL2069404)Show SMILES CN1CCN(CC1)c1cccc2OC[C@H](Cc12)NC(=O)c1nn(nc1C)-c1ccc(C)cc1C |r| Show InChI InChI=1S/C26H32N6O2/c1-17-8-9-22(18(2)14-17)32-28-19(3)25(29-32)26(33)27-20-15-21-23(6-5-7-24(21)34-16-20)31-12-10-30(4)11-13-31/h5-9,14,20H,10-13,15-16H2,1-4H3,(H,27,33)/t20-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2.51E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description Inhibition of human NaV1.5 expressed in CHO cells by IonWorks assay |
Bioorg Med Chem Lett 22: 5618-24 (2012)
Article DOI: 10.1016/j.bmcl.2012.06.105 BindingDB Entry DOI: 10.7270/Q2ZC83ZX |
More data for this Ligand-Target Pair | |